https://www.selleckchem.com/products/cp-43.html
Non-steroidal anti-inflammatory drugs (NSAIDs) are the most commonly prescribed medications for alleviating pain and inflammation but may cause gastrointestinal tract damage. Proton pump inhibitors (PPI) prevent NSAID-induced gastric damage but may aggravate intestinal damage via dysbiosis and intestinal permeability alteration. Currently, there is growing interest regarding the influence of potassium competitive acid blockers (PCA on NSAID-induced enteropathy. Here, we investigated the relative changes in indomethacin-induced enteropat
إعجاب
علق
شارك
